当前位置: X-MOL 学术Am. J. Physiol. Renal Physiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mutation of RORγT reveals a role for Th17 cells in both injury and recovery from renal ischemia reperfusion injury.
American Journal of Physiology-Renal Physiology ( IF 3.7 ) Pub Date : 2020-09-14 , DOI: 10.1152/ajprenal.00187.2020
Purvi Mehrotra 1 , Md Mahbub Ullah 1 , Jason A Collett 1 , Sarah L Myers 1 , Melinda R Dwinell 2 , Aron M Geurts 2 , David P Basile 1
Affiliation  

To investigate Th17 cells in the setting of acute kidney injury (AKI), the master regulator of Th17 cell differentiation, RORγT, was mutated in Lewis rats using CRISPR/Cas9 technology. In response to 40 min bilateral renal I/R, Rorc-/- rats were resistant to injury relative to wild-type Rorc+/+ rats. This protection was associated with inhibition of IL17 expression and reduced infiltration of CD4+ cells, CD8+ cells, B-cells and macrophages. To evaluate the effect of Th17 cells on repair, ischemia was increased to 50 min in Rorc-/- rats. This maneuver equalized the initial level of injury in Rorc-/- and Rorc+/+ rats 1 to 2 days post I/R based on serum creatinine values. However Rorc-/- rats, but not Rorc+/+ rats, failed to successfully recover renal function and had high mortality by 4 days post I/R. Kidney tubules from Rorc+/+ rats showed evidence of repair by day-4 post I/R, while Rorc-/- rats showed persistent necrosis and elevated cell proliferation. Adoptive transfer of CD4+ cells from spleen of Rorc+/+ rats or supplementation of exogenous rIL17 by osmotic mini-pump improved renal function and survival of Rorc-/- rats following 50 min of I/R. This was associated with a relative decrease in the number of M1-type macrophages and a relative increase in the percentage of T-regulatory cells. Taken together, these data suggest Th17 cells have both a deleterious and beneficial role in kidney injury and recovery, contributing to early post-ischemic injury and inflammation but may also be critical in resolution of inflammation during kidney repair.

中文翻译:

RORγT 的突变揭示了 Th17 细胞在肾缺血再灌注损伤的损伤和恢复中的作用。

为了研究急性肾损伤 (AKI) 环境中的 Th17 细胞,使用 CRISPR/Cas9 技术在 Lewis 大鼠中突变了 Th17 细胞分化的主要调节因子 RORγT。响应 40 分钟双侧肾 I/R,Rorc -/-大鼠相对于野生型 Rorc +/+大鼠对损伤具有抵抗力。这种保护作用与抑制 IL17 表达和减少 CD4+ 细胞、CD8+ 细胞、B 细胞和巨噬细胞浸润有关。为了评估 Th17 细胞对修复的影响,将 Rorc -/-大鼠的缺血时间增加到 50 分钟。根据血清肌酐值,该操作在 I/R 后 1 至 2 天平衡了 Rorc -/-和 Rorc +/+大鼠的初始损伤水平。然而罗克-/-大鼠,但不是 Rorc +/+大鼠,未能成功恢复肾功能,并且在 I/R 后 4 天具有高死亡率。Rorc +/+大鼠的肾小管在I/R 后第 4 天显示出修复迹象,而 Rorc -/-大鼠显示出持续性坏死和细胞增殖升高。从 Rorc +/+大鼠脾脏中过继转移 CD4+ 细胞或通过微型渗透泵补充外源性 rIL17 改善了 Rorc -/- 的肾功能和存活率I/R 50 分钟后的大鼠。这与 M1 型巨噬细胞数量的相对减少和 T 调节细胞百分比的相对增加有关。总之,这些数据表明 Th17 细胞在肾损伤和恢复中具有有害和有益作用,有助于早期缺血后损伤和炎症,但也可能对肾脏修复过程中炎症的消退至关重要。
更新日期:2020-09-15
down
wechat
bug